Antipodes Partners’s Nu Holdings NU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.7M Buy
4,689,670
+496,718
+12% +$6.7M 1.15% 40
2026
Q1
$60.3M Buy
4,192,952
+785,026
+23% +$12.7M 1.16% 39
2025
Q4
$57.1M Sell
3,407,926
-84,291
-2% -$1.35M 1.2% 36
2025
Q3
$55.9M Buy
3,492,217
+957,531
+38% +$13.4M 1.25% 32
2025
Q2
$34.8M Buy
2,534,686
+2,501,647
+7,572% +$30M 1.08% 28
2025
Q1
$338K Buy
33,039
+11,883
+56% +$140K 0.01% 51
2024
Q4
$219K Buy
21,156
+5,739
+37% +$76.3K 0.01% 55
2024
Q3
$210K Sell
15,417
-1,449
-9% -$19.5K 0.01% 55
2024
Q2
$217K Sell
16,866
-5,512
-25% -$64.2K 0.01% 52
2024
Q1
$267K Sell
22,378
-7,271
-25% -$74.2K 0.01% 46
2023
Q4
$246K Buy
29,649
+1,744
+6% +$14.1K 0.01% 48
2023
Q3
$203K Buy
27,905
+18,268
+190% +$137K 0.01% 49
2023
Q2
$76K Sell
9,637
-6,514
-40% -$40K ﹤0.01% 53
2023
Q1
$76K Buy
+16,151
New +$72K ﹤0.01% 50

Other funds holding NU

Antipodes Partners's NU Position: Q2 2026 in Review

Antipodes Partners increased its Nu Holdings (NU) stake by 12% in Q2 2026, buying an estimated $6.7M and bringing the position to 4,689,670 shares worth $62.7M. The position accounts for 1.15% of the portfolio, ranked #40.

Antipodes Partners first reported a position in NU in Q1 2023 and has held it in 14 quarters since. 853 funds tracked by Wall St. Rank hold NU as of Q2 2026.

  • Antipodes Partners held 4,689,670 shares of Nu Holdings worth $62.7M as of Q2 2026.
  • Antipodes Partners bought 496,718 Nu Holdings shares in Q2 2026, an estimated $6.7M.
  • Nu Holdings made up 1.15% of Antipodes Partners's portfolio in Q2 2026, its #40 holding.
  • Antipodes Partners first reported a position in Nu Holdings in Q1 2023 and has held it in 14 quarters since.
  • 853 funds tracked by Wall St. Rank held Nu Holdings as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.